PPT-EARS-Net data on antimicrobial resistance in

Ireland Quarter 14 2017 20 th June 2018 KEY POINTS 2017 General Increasing numbers of invasive infections in recent years due to the following pathogens K pneumonaie P aeruginosa S . Director, The National Antimicrobial Resistance Monitoring System. U.S. Food & Drug Administration. Center for Veterinary Medicine . Office of Research. Laurel, MD USA. The National Antimicrobial Resistance Monitoring System. N. gonorrhoeae. . A Review. INTRODUCTION. Progressive antimicrobial resistance in . Neisseria gonorrhoeae . is an emerging public health threat. The Public Health Agency of Canada (the Agency) released updated recommendations in July 2013 for the diagnosis, treatment, follow-up and reporting of gonorrhea. Presenter. date. Supporting healthcare professionals . in the fight against resistance. Expand the standardized antimicrobial web based PPS at a global scale to collect consistent, valid and comparable antimicrobial prescribing data.. Director, The National Antimicrobial Resistance Monitoring System. U.S. Food & Drug Administration. Center for Veterinary Medicine . Office of Research. Laurel, MD USA. The National Antimicrobial Resistance Monitoring System. . Dr Andrea Ammon, ECDC Director, . 27 June 2017, European Parliament. 0. 200. 400. 600. 800. 1000. 1900. 1920. 1940. 1960. 1980. 2000. 1918. Influenza pandemic. 1924. Plague: last human-to-human transmission. Director, The National Antimicrobial Resistance Monitoring System. U.S. Food & Drug Administration. Center for Veterinary Medicine . Office of Research. Laurel, MD USA. The National Antimicrobial Resistance Monitoring System. a pharmaceutical industry perspective. 17. th. November 2018. Dr Bryan Deane. Dept of Research, Medical & Innovation . Introduction – the ABPI; the biopharmaceutical industry. AMR: the issue. Antibiotics. Antimicrobial drugs naturally produced by microorganisms. Penicillium. . species: . Penicillins. Cephalosporium. . specis. : . cephalosporins. Streptomyces. . species:. . lincosamides. Ireland. Quarter 1-4 2017. 20. th. June 2018. KEY POINTS, 2017 (General). Increasing numbers of invasive infections in recent . years due to the following pathogens. : . K. . pneumonaie. , . P. . aeruginosa, S. . Insert your organisation’s name here . Insert presenter’s name here . #. worldantimicrobialawarenessweek. Overview. Antibiotics are . vital life-saving . medicines . Antimicrobial resistance is both a global and local problem. Therapy. The development of antimicrobial drugs represents one of the most important advances in therapeutics, both in the control or cure of serious infections and in the prevention and treatment of infectious complications of other therapeutic modalities such as cancer chemotherapy, immunosuppression, and surgery.. Consequences of AMR. What can we do ?. Microbiology and the antibiotic apocalypse. Dr Dave Whitworth. dew@aber.ac.uk. Reader in Biochemistry. Microbiology and the antibiotic apocalypse. What are antibiotics ?. Resistance : T ackling a crisis for the health and wealth of nations The Review on Antimicrobial Resistance Chaired by Jim O’Neill December 2014 Contents What is antimicrobial resistance? 1. 1. Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings//BMC Infectious Diseases.- volume 19, Article number: 768 (2019) . Educational MODULE. November 2020.